Navigation Links
EntreMed to Present at BioCentury Future Leaders in the Biotech Industry Conference
Date:3/25/2008

ROCKVILLE, Md., March 25 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD) a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced that James S. Burns, President and Chief Executive Officer, will present a Corporate overview at the BioCentury Future Leaders in the Biotech Industry Conference, to be held at the Millennium Broadway Hotel & Conference Center, March 27, 2008. Mr. Burns' presentation is scheduled for Thursday, March 27, 2008 at 4:00 p.m. (local time).

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO )

Mr. Burns' live presentation will be web cast and can be accessed through the Company's web site at http://www.entremed.com. An archive will be available on the web site for approximately 90 days.

About EntreMed

EntreMed, Inc. is a clinical-stage pharmaceutical company developing therapeutic candidates primarily for the treatment of cancer and inflammation. MKC-1 is currently in multiple Phase 2 clinical trials for cancer. MKC-1 is an oral cell-cycle regulator with activity against the mTOR pathway. ENMD-1198, a novel antimitotic agent, is in a Phase 1 study in advanced cancer patients, and ENMD-2076, a selective kinase inhibitor, is expected to begin a Phase 1 study in 2Q08. The Company also has an approved IND application for Panzem(R) in rheumatoid arthritis. EntreMed's goal is to develop and commercialize new compounds based on the Company's expertise in angiogenesis, cell-cycle regulation and inflammation -- processes vital to the treatment of cancer and other diseases,
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. EntreMed Announces 2008 Corporate and Clinical Program Priorities
2. EntreMed Reports Fourth Quarter and Year-End 2007 Financial Results
3. EntreMed to Present at BIO CEO and Investor Conference
4. EntreMed Presents Interim Results for Phase 2 Carcinoid Tumor Study
5. EntreMed Announces FDA Acceptance of IND Application for Aurora Kinase/Angiogenesis Inhibitor, ENMD-2076
6. EntreMed Appoints Senior Vice President of Research and Development
7. EntreMed to Present at ThinkEquity Partners 5th Annual Growth Conference
8. Osteotech to Present at the Sidoti Conference in New York
9. BioMS Medical to present at BioCentury Conference
10. Biodel Inc. to Present at the BioCentury Future Leaders Conference on March 27th, 2008
11. Evotec AG: Fiscal Year 2007 Results Presentation on March 28, 2008 Live on the Internet

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., TSXVENTURE:HTL , TORONTO,Nov.24/PRNewswi...lyCalottoCapitalInc.,aleadingproviderofadvancedlas...rtilityclinicmarkets,todayreportedoperationalandfi...009. , ,Q32009Highlights,-Revenuewas$1.46million...nwas66.3percentcomparedwith66.1percentinQ3,2008,-N...
(Date:11/24/2009)..., REDWOODCITY,Calif.,Nov.24/PRNewswire-FirstCal...dthatRandyScott,GenomicHealth,sExecutiveChairman,w...ferenceinNewYorkCityonTuesday,December1,2009at10:0...vedwebcastofthepresentation,visittheInvestorRelati...or.genomichealth.com .Pleaseconnecttothewebsiteatl...
(Date:11/24/2009)... Chemical Abstracts Service ...reports that China,s patent office is now the worl...ons in chemistry. China trailed Japan,s patent off...(WIPO), and the United States Patent and Trademark... the USPTO in 2005, WIPO in 2006, and exceeded Jap...
(Date:11/23/2009)...HAMPAIGN, Ill. You can think of it as origami ve...sity of Illinois have developed a technique for fa...licon structures from thin films by coupling photo...apillary interactions. , The films, only a few mi...not possible with thicker pieces of the same mater...
Breaking Biology Technology:Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Genomic Health to Present at Piper Jaffray Health Care Conference 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3Water droplets direct self-assembly process in thin-film materials 2
...s Product Suite by Adding Price Transparency, VER...wswire-FirstCall/,-- Concuity, a healthcare divisi...ider of contract management and revenue recovery t...today announced its partnership with,Financial Hea...sed solution,for credible procedural price estimat...
...June 23 diaDexus, Inc.,today announced the releas...ology, Vol. 101, No 12A June 16, 2008 that include...ude testing for,lipoprotein-associated phospholipa...marker, as an adjunct to traditional cardiovascula...ions are consistent with and build,on the Adult Tr...
...sdaq: WHRT ) World,Heart Corporation ("WorldHeart...pitalization Agreement dated June 20, 2008 among W...rt Inc. ("WHI"), Abiomed, Inc.,("Abiomed"), Venroc...,Venrock Entrepreneurs Fund V, L.P. (collectively,...ecial Situations Cayman Fund, L.P., Special,Situat...
Other Biology Technology:Concuity Announces Partnership with Financial Healthcare Systems, LLC 2Concuity Announces Partnership with Financial Healthcare Systems, LLC 3Concuity Announces Partnership with Financial Healthcare Systems, LLC 4Expert Consensus Panel Recommendation for Incorporating Lp-PLA2 Testing into Cardiovascular Disease Risk Assessment Guidelines 2Expert Consensus Panel Recommendation for Incorporating Lp-PLA2 Testing into Cardiovascular Disease Risk Assessment Guidelines 3Expert Consensus Panel Recommendation for Incorporating Lp-PLA2 Testing into Cardiovascular Disease Risk Assessment Guidelines 4WorldHeart Enters into a Recapitalization Agreement and Receives Bridge Financing 2WorldHeart Enters into a Recapitalization Agreement and Receives Bridge Financing 3WorldHeart Enters into a Recapitalization Agreement and Receives Bridge Financing 4WorldHeart Enters into a Recapitalization Agreement and Receives Bridge Financing 5WorldHeart Enters into a Recapitalization Agreement and Receives Bridge Financing 6
(Date:11/24/2009)...Spanish . , The presence of increased body f...bstances in the blood, hinders the loss and mainte...ct of the University of Navarra conducted by Estba...Pharmacy. , The project, entitled "A nutrigeneti...l of body weight and inflammation," examines how t...
(Date:11/23/2009)...-associated strain of the deadly superbug MRSAan i... antibioticsposes a far greater health threat than...tals, according to a study in the December issue o...eat is easily picked up in fitness centers, school...verall burden of MRSA within hospitals, the report...
(Date:11/23/2009)...The time of day matters to forest trees dealing wi... research team led by Professor Malcolm Campbell, ... for research and colleagues in the department of ... , Capitalizing on their previous work to deco...m examined how poplar trees use their 45,000 genes...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2New study finds MRSA on the rise in hospital outpatients 2Time of day matters to thirsty trees, U of T researcher discovers 2Home Delivery Medical Launches New Division For Sleep Centers 55431 1Home Delivery Medical Launches New Division For Sleep Centers 55431 2Home Delivery Medical Launches New Division For Sleep Centers 55431 3Monitoring for Fever Can Help With Early Detection of H1N1 Swine Flu 55427 1Monitoring for Fever Can Help With Early Detection of H1N1 Swine Flu 55427 2New Precision Radiation Treatment System Fights Cancer 55423 1New Precision Radiation Treatment System Fights Cancer 55423 2New Precision Radiation Treatment System Fights Cancer 55423 3
... Good news for public health: Bioengineering rese...ve developed and patented a nanoparticle that can ... effects, and at a fraction of the cost of current... appearing online September 16 in the journal Natu... a deceptively simple combination of nanotechnolog...
... PROVIDENCE, R.I. [Brown University] Brown Unive...the sweet smell of fresh dirt. In Nature Chemical ...t makes geosmin source of the good earth scent h... critical role in making this organic compound. , ...warm earth, said David Cane, professor of chemistr...
... , MADISON, WI, JULY 18, 2007 The Yam bean origina... grown in South and Central America, South Asia, E...species which are called the Amazonian, Mexican an...n fertile and stable hybrids. This gives it potent...e high quality food production and offer a sustain...
Other Biology News:New nanoparticle vaccine is more effective but less expensive 2New nanoparticle vaccine is more effective but less expensive 3Good earth: Brown chemists show origin of soil-scented geosmin 2Yam bean a nearly forgotten crop 2
BD BioCoat Collagen I 35 mm Culture Dishes from BD Biosciences - Discovery Labware
Corning C ulture Dishes, 150X25 mm, Tc-Treated, PS, Sterile from Sigma-Aldrich
Corning C ulture Dishes, 245 mm2 X 25 mm H, 500Cm2, Sterile from Sigma-Aldrich
BD BioCoat Collagen IV 150 mm Culture Dishes from BD Biosciences - Discovery Labware
Biology Products: